LncRNAs and their role in cancer stem cells

Shusen Chen; Jiamin Zhu; Feng Wang; Zhifeng Guan; Yangyang Ge; Xi Yang; Jing Cai

doi:10.18632/oncotarget.22161

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

LncRNAs and their role in cancer stem cells

Shusen Chen, Jiamin Zhu, Feng Wang, Zhifeng Guan, Yangyang Ge, Xi Yang and Jing Cai _

PDF | HTML | How to cite

Oncotarget. 2017; 8:110685-110692. https://doi.org/10.18632/oncotarget.22161

Metrics: PDF 3619 views | HTML 4774 views | ?

Abstract

Shusen Chen1,*, Jiamin Zhu1,*, Feng Wang1,*, Zhifeng Guan1, Yangyang Ge1, Xi Yang2 and Jing Cai1

1Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, 226321, China

2Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China

*These authors have contributed equally to this work

Correspondence to:

Jing Cai, email: [email protected]

Xi Yang, email: [email protected]

Keywords: cancer stem cells; lncRNA; cancer biology

Received: June 14, 2017 Accepted: September 08, 2017 Published: October 30, 2017

ABSTRACT

Cancer stem cells (CSCs) play a vital role in the formation of tumors and have been studied as a target of anticancer therapy. Long non-coding RNAs (lncRNAs) are important in the genesis and progression of cancer. Various lncRNAs, such as ROR, HOTAIR, H19, UCA1, and ARSR, are involved in cancer stemness. These lncRNAs could regulate the expression of CSC-related transcriptional factors, such as SOX2, OCT4, and NANOG, in colorectal, prostate, bladder, breast, liver, and other cancer types. In this work, we review the progress of lncRNAs and cancer stem cells and discuss the potential signal pathways of lncRNAs in cancer stemness.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22161

Publication Alerts

Post-Publication Promotion

Reviews:

LncRNAs and their role in cancer stem cells

Abstract